Eventide Asset Management - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q1 2021$19,379,000
+6.0%
142,9000.0%0.29%
+2.5%
Q4 2020$18,283,000
+13.7%
142,9000.0%0.28%
-11.1%
Q3 2020$16,081,000
+18.1%
142,9000.0%0.32%
+6.4%
Q2 2020$13,614,000
+6.0%
142,9000.0%0.30%
-28.8%
Q1 2020$12,842,000
+113.9%
142,900
+10.9%
0.42%
+101.0%
Q1 2019$6,003,000
+6.9%
128,9000.0%0.21%
-16.9%
Q4 2018$5,614,000
-23.9%
128,9000.0%0.25%
-8.1%
Q3 2018$7,377,000
-71.3%
128,900
-75.7%
0.27%
-74.6%
Q2 2018$25,711,000
+24.1%
529,9000.0%1.07%
+10.0%
Q1 2018$20,719,000
-25.3%
529,900
-19.0%
0.97%
-33.0%
Q4 2017$27,752,000
+13.7%
653,9000.0%1.45%
+4.6%
Q3 2017$24,404,000
+22.8%
653,9000.0%1.38%
+11.8%
Q2 2017$19,872,000
+14.8%
653,9000.0%1.24%
+7.9%
Q1 2017$17,309,000
+58.1%
653,900
+52.5%
1.15%
+61.0%
Q4 2016$10,946,000
-29.5%
428,9000.0%0.71%
-24.9%
Q3 2016$15,522,000
+6.5%
428,9000.0%0.95%
+6.3%
Q2 2016$14,574,000
+30.4%
428,900
+1.3%
0.89%
+42.9%
Q1 2016$11,176,000
+85.6%
423,500
+242.9%
0.62%
+107.3%
Q4 2015$6,022,000
+177.6%
123,500
+41.8%
0.30%
+138.9%
Q3 2015$2,169,000
-21.3%
87,1000.0%0.13%
-15.4%
Q2 2015$2,756,000
-16.9%
87,1000.0%0.15%
-40.2%
Q1 2015$3,315,000
+37.0%
87,100
+40.3%
0.25%
-5.7%
Q4 2014$2,419,000
+28.8%
62,1000.0%0.26%
+0.8%
Q3 2014$1,878,000
-11.0%
62,1000.0%0.26%
-8.7%
Q2 2014$2,110,00062,1000.29%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,505,012$204,095,00039.96%
Foresite Capital Management III, LLC 108,630$14,731,00012.94%
Avoro Capital Advisors LLC 3,000,000$406,830,0007.03%
Octagon Capital Advisors LP 112,363$15,238,0005.74%
Artal Group S.A. 1,400,000$189,854,0003.36%
Eversept Partners, LP 241,981$32,815,0432.47%
NWI MANAGEMENT LP 200,000$27,122,0002.26%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,500$8,199,0002.17%
Affinity Asset Advisors, LLC 45,000$6,102,0002.07%
Parkman Healthcare Partners LLC 62,780$8,514,0001.98%
View complete list of ACCELERON PHARMA INC shareholders